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THE CLONING FOR BIOMEDICAL RESEARCH DEBATE:
DO THE PROMISES OF MEDICAL ADVANCES OUTWEIGH
THE ETHICAL CONCERNS?
t

Jessica J. Monachello
I. INTRODUCTION

Cloning is one of the most debated topics both in the United States
and around the world.1 Although cloning to produce children has been
banned in most countries, cloning for biomedical research is still a topic of
debate. This comment will focus on cloning for biomedical research.
There are countries that are against cloning for biomedical research or that
are proposing a moratorium on it, such as the United States,' while others
that are taking great leaps towards making cloning for biomedical research
a reality. The United Kingdom is such a country.3
This section will define cloning for biomedical research and stem cells,
and will outline the potential benefits of such research. Part II will
describe the history of cloning for biomedical research in the United States
and what legislative measures are being proposed by the executive and
legislative branches of the United States goverment. Part III will describe
what regulations are in place in other countries and how they are
This comment concludes by
approaching this controversial topic.

J.D., University of Tulsa College of Law, Tulsa, Oklahoma, May 2004; B.S., Chemical
Engineering, University of Tulsa, Tulsa, Oklahoma, December 1998. The author wishes to
dedicate this comment to her loving husband, Scott, for his continued support and never
ending devotion. The author also wishes to thank her parents, Norberto and Marisabel
Nicoletti, for teaching her that through hard work all dreams can come true.
1. See THE PRESIDENT'S COUNCIL ON BIOETHICS, HUMAN CLONING AND HUMAN
AN ETHICAL INQUIRY (July 2002),
cloningreport/index.html (last visited Mar. 6, 2003).
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proposing that cloning for biomedical research be allowed in the United
States, contingent upon oversight by a regulatory committee. This will not
only allow the United States to continue to be a leader in biotechnology,
but also provide incentives for scientists to develop potential cures or
treatments for the ailing people of this country.
Definitions and BackgroundInformation
Cloning for biomedical research is labeled in many ways, including
"therapeutic cloning" and "human embryonic cloning.",4 This comment
adopts the definition and label used by the President's Council on
Bioethics in its July 2002 report to the President of the United States.5 It
defines "cloning-for-biomedical-research" as the "production of a cloned
human embryo, formed for the (proximate) purpose of using it in research
or for extracting its stem cells, with the (ultimate) goals of gaining scientific
knowledge of normal and abnormal development and of developing cures
of human diseases." 6 Cloning a human embryo is

A.

accomplished by introducing the nuclear material of a human somatic
cell (donor['s cell other than a sperm or egg celli) into an oocyte (egg)
whose own nucleus has been removed or inactivated, yielding a product
that has a human genetic constitution virtually identical to the donor of
the somatic cell. (This procedure is known as "somatic cell nuclear
transfer," or SCNT). 7
During human embryonic development a single cell (the fertilized
egg) differentiates into more than 200 cell types that make up the human
body.8 Up to about the eight-cell stage in the fertilization process all cells
are "totipotent" (i.e. they can develop into any cell of the human body). 9
After five days, the cells have divided into approximately 50-100 cells
(blastocyst stage), from which stem cells can be removed." Human
embryonic stem cells have the capacity of being transformed into almost
any of the 200 types of cells in the human body. 1
4. See Nicholas Wade, World War Breaks Out in Research on Stem Cells, N.Y. TIMES,
Dec. 21, 2002, at Al.
5. THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 1.
6. Id.
7. Id.
8. The United Kingdom Parliament, Stem Cell Research Committee, para. 2.2, Feb. 13,
2002, at http://www.parliament.the-stationery-office.co.uk/pald/ldstem.htm [hereinafter
UK Committee].
9. Id. para. 2.3.
10. Id.
11. Daniella Goldberg, Cloning Around with Stem Cells, ABC SCIENCE ONLINE, at
http://abc.net.au/science/slab/stemcells/default.htm (last visited Mar. 6, 2003).
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Stem cells can be harvested from an early embryo but they can also be
harvested from a fetus, from the placenta and umbilical cord, and from
many other tissues of the body. 2 Stem cells harvested after the blastocyst
stage (i.e. stem cells extracted past the 50-100 cell division or stem cells in
the placenta and umbilical cord, also called adult stem cells) are described
as "multipotent" as they have the potential to differentiate into a limited
number of cells of the human body.13
B.

Benefits of Cloningfor Biomedical Research
Many scientists believe that there are tremendous possibilities for
benefits to the human race if cloning for biomedical research is allowed.
Because human embryonic stem cells have the ability to differentiate into
other cell types, they offer the potential to cure diseases such as cancer,
diabetes, Parkinson's, Alzheimer's, multiple sclerosis and certain forms of
heart disease.' 5 They also offer the potential to help treat nervous system
injuries, spinal cord injuries, and severe burns."
Professor Bernie Tuch, Director of the Pancreas Transplant Unit at
Prince of Wales Hospital in Sydney, Australia, is seeking a cure for
diabetes through the use of human embryonic stem cells. 7 Professor Tuch
believes that using stem cells might provide a way to replace the "insulinproducing cells that are missing in type I diabetes patients," thereby
reversing the disease and eliminating the need for insulin injections18
Dr. Leon McQuade, a molecular geneticist in the same hospital, has
been working for months to turn mouse embryo cells into insulinproducing cells) 9 He believes that since these insulin-producing cells have
been achieved in mice, soon the same achievement could be made for
humans. Dr. Karl Skorecki's team, at the Technion in Haifa, Israel, has
also been performing the same tests on mice; his concern is how to apply
this type of stem cell therapy to humans without using immuno-

12. UK Committee, supra note 8, para. 2.3.
13. Id. para. 2.4.
14. See Cell Biology: Study on Adult Blood Stem Cells Raise Questions, BLOOD WEEKLY,
Oct. 31, 2002, availableat 2002 WL 9268282 [hereinafter Cell Biology].
15. See Gabriel S. Gross, FederallyFunding Human Embryonic Stem Cell Research: An
AdministrativeAnalysis, 2000 WiS. L. REV. 855, 856 (2000).
16. See id.
17. Goldberg, supra note 11.
I& Id.
19. Id.
20. Id.
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suppressive drugs, which sometimes have been known to produce serious
side effects.2'
The immuno-suppressive drug problem could be overcome by using a
patient's adult cell, inserting it into an egg that has had its nucleus removed
(i.e., SCNT), thus creating a human embryo and removing its stem cell.
But as Dr. Quade points out, more tests are necessary to ensure that the
cells continue to function properly after they are inserted into the patients'
23
body even if no problems with rejection are encountered .
Professor Alan Trounson's team, at Melbourne Monash University in
Australia, has successfully created "mature nerve cells from human
embryonic stem cells. 24 His team then successfully implanted these cells
into newborn mice and the cells seem to be acting as normal brain cells."
This type of success, if applied to humans, could6 lead to the treatment of
neurodegenerative diseases such as Parkinson's.1
Although some people believe that adult stem cells should be used for
research in lieu of embryonic stem cells, recent findings have shown that
adult stem cells might not hold the promised value in the treatment of
diseases.27 Researchers at Stanford tried to trace how blood stem cells
adapted after being inserted into mice whose bone marrow had been
destroyed." They hoped these cells would generate both blood-making
cells as well as cells that would generate other tissues of the body.2 9 The
researchers found that the blood stem cells only made blood cells, not any
other types of cells. 0 The Stanford researchers stated that their study
shows the only sure way of making multiple tissues from one cell is from
embryonic stem cells, not from adult blood stem cells.3'

However,

accordingly to Dr. Dennis Steindler, a stem cell researcher at the
University of Florida, there is still too much research to be done on this
subject and most experts believe that both adult and embryonic stem cell
research should continue because it might lead to cures or new therapies
for diseases.32
21. Id.
22 Id.
23. Goldberg, supra note 11.
24. Id.
25. Id.

26.
27.
28.
29.
30.
31.
32.

Id.
See Cell Biology, supra note 14.
Id.
Id.
Id.
Id.
See id.
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II. CLONING FOR BIOMEDICAL RESEARCH IN THE UNITED STATES

In November 1998, Dr. James A. Thomson, a biologist at the
University of Wisconsin, was the first to isolate an embryonic stem cell.33
His work did not qualify for National Institute of Health (NIH) funding, so
he started a separate lab with private funds to do his research.34 Until
2001, the federal government had not provided any funding for human
embryonic stem cell research.35 After Dr. Thomson's announcement,
President Bill Clinton created the National Bioethics Advisory
Commission (NBAC) to review the issues concerning stem cell research.36
In 1999, the NBAC released a report concluding "that the federal
government should fund research on, and the derivation of, human ES
[embryonic stem] cells, provided that only embryos leftover from fertility
treatments were used.

37

The commission also proposed that Congress

create an exception to the embryo research ban for the derivation of
embryonic stem cells

3

In December of 1999, the National Institute of Health released a draft
of its guidelines permitting federal funds to be given to privately funded
research on embryonic stem cells, but with stringent oversight. 39 The
guidelines only allowed research on cells derived from leftover or donated
embryos from fertility treatments.4 ° The final guidelines, released August
25, 2000 and backed by President Clinton, led to the solicitation of
research grants. 1 A committee was set up to review grant applications to
the NIH, but the first meeting in April 2001 was canceled as President
Bush ordered the Secretary of the Department of Health and Human

33. American Association for the Advancement of Science, Stem Cell Research, at
http://www.aaas.org/spp/cstc/issues/stemcells.htm (last modified Aug. 14, 2002) [hereinafter
AAAS].
34. Id. Dr. Thomson's work was not eligible for funding because Congress put a ban on
National Institute of Health (NIH)-funded human embryo research. In 1995, Congress
attached the ban to a bill that gave NIH funds and it was retained each time the bill was
appropriated. Because of this, the NIH contacted the Department of Health and Human
Services (HHS) for counseling, and in 1999, the HHS declared that public funds could be
used for research on human embryonic cells as long as the derivation of the cells that result
in the termination of an embryo is carried out with private funds. Id.
35. Id.

36. Id.
37. Id.

38.
39.
40.
41.

AAAS, supra note 33.
Id.
Id.
Id.
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Services (HHS) to review the guidelines.42 Despite this seeming setback,
researchers at Advanced Cell Technology, a company in the United States,
claimed to have produced the first cloned human embryo in November
2001.4' Although no stem cells were harvested, it was the longest surviving
embryo to be cloned. 44
A.

President'sView
President George Bush addressed human embryonic stem cell
research and funding during his speech to the nation on August 9, 2001,
due to substantial pressure from scientists, religious groups, and the public
in general.4 5 The President noted there was a fear that if federal funds
were not provided to continue the research on stem cells in the United
States, the country would lose not only its best and brightest scientists, but
also lose its standing as a leader in science and medicine." The President
indicated that after much deliberation into the moral and ethical issues, he
decided that federal funds would only be available for research on existing
stem lines that have been derived: with the donors' informed consent, from
excess embryos from fertility treatments, and without giving the donors
any financial incentives. 47 To ensure these standards are followed and that
the research conducted is both legal and ethical, he required that the NIH
"examine the derivation of all existing stem cell lines and create a registry
of those lines that satisfy this criteria."' '
In the press release accompanying the speech, the White House noted
that probably around sixty existing stem cell lines from around the world
would fit the President's requirements and therefore be acceptable for
federal funding. 49 He also stated that federal funds would not be granted
for stem cell lines derived from newly destroyed embryos, for the creation
of human embryos specifically for research, or for the cloning of human
embryos. 0

42. Id.

43. Goldberg, supra note 11.
44. Id. The embryo only reached the six-cell stage. Id.

45. See President Gcorge W. Bush, Remarks by the President on Stem Cell Research to
the Nation (Aug. 9, 2001), available at http://www.whitehouse.gov/news/releases/
2001/08/print/20010809-2.html [hereinafter Bush].
46. See id.

47. Press Release, The White House: Office of the Press Secretary, Embryonic Stem
Cell Research (Aug. 9, 2001), at http://www.whitehouse.gov/news/releases/2001/08/print/
20010809-1.html.
48. Id.

49. Id.
50. Id.
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Following the President's announcement, the NIH started to
implement the President's policy." The NIH consulted with scientists
around the world and found that there were sixty-four individual
blastocysts that fit the President's guidelines.52 The NIH created the
Human Embryonic Stem Cell Registry, which has a list of all the human
embryonic stem cell lines that meet the President's standards.
On February 28, 2002, the NIH noted that scientists were already
encountering difficulties with the standards set by the President.54 The first
difficulty concerns the supply of the existing stem cell lines; since these
lines were only developed three years ago, the creators are still refining
55
them, categorizing them and developing procedures to share their cells.
The second difficulty relates to the technique used to develop embryonic
stem cells, as the WiCell Research Institute holds the patent to this
technique.56 However, the NIH has been working with the WiCell
Research Institute to set up licensing agreement to ease this problem.57 A
third problem that scientists may face is that most of the embryonic stem
cells were created outside the.United States; therefore, not only is there a
58
geographical issue, but also a legal problem.
Other countries either
already have their own legislation or are planning to set their own
guidelines regarding to the use of their existing stem cell lines. 9 At this
time, the NIH is also trying to assist scientists by discussing these issues
with the government of these countries, but this will further delay the
process.60 Finally, the NIH wants to educate scientists in the community
and to create interest in this type of research." Because this field is so
new, there are not enough trained scientists in the United States ready to
undertake the research; therefore, the NIH is providing a variety of

51. National Institutes of Health, National Institutes of Health (NIH) Update on Existing
Human Embryonic Stem Cells, Aug. 27, 2001, at http://www.nih.gov/news/stemcell/
0827011ist.htm.
52. Id.
53. National Institutes of Health, NIH Strategies for Implementing Human Embryonic
Stem Cell Research, Feb. 28, 2002, at http://www.nih.gov/news/stemcell/022802implem
ent.htm.
54. Id.
55. Id.

56. Id.
57. Id.
58. Id.
59. See National Institutes of Health, supranote 53.

60. Id.
61, Id.
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training opportunities
for scientists from tutorials to symposia and
61
fellowships.
On September 25, 2002, Dr. Elias Zerhouni, the Director of the NIH,
testified before the Senate regarding the developments in Stem Cell
Research in the United States." With regard to the problems encountered,
Dr. Zerhouni reaffirmed that there was still a shortage of talented
researchers in stem cell research and that there were still problems in the
availability of the existing stem cells, but that the NIH was trying to
ameliorate these problems by training scientists and granting awards to
expand the available stem cells.6
Dr. Zerhouni mentioned that the research was still at its early stages
as the NIH is still trying to draw the "most talented research scientists" to
this type of research." He also stated that the NIH was in the process of
"supporting infrastructure awards to expand [existing] cell lines, refine
culture methods, and establish improved methods to select the most
desirable embryonic stem cell populations." ' He indicated that the NIH is
supporting research on adult stem cells lines to potentially develop
therapies from these cell lines. 6' However, Dr. Zerhouni noted that he
believed both research on the existing embryonic stem cells as well as on
adult stem cells should continue simultaneously so that the potential of
these cells tos treat and develop new cures for human diseases can be fully
understood .681

Dr. Zerhouni noted that the technology required to treat human
diseases would require years to develop.69 Before that can happen,
scientists first would have to perform pre-clinical studies with non-human
subjects. 0 These studies would include tests of long-term survival of the
cells and "tests of the safety, toxicity, and effectiveness of the cells in
treating animal models for disease., 7' The first phase of clinical trials on

62. Id.
63. Hearing on Stem Cell Research, Senate AppropriationsCommittee, Subcommittee on
Labor, Health, Human Services, Education and Related Agencies, 107th Cong. (Sept. 25,

2002) [hereinafter Zerhouni] (statement of Dr. Elias Zerhouni, Director, NIH).
64.
65.
66.
67.
68.
69.
70.
71.

Id.
Id.
Id.
Id.
Id.
See Zerhouni, supra note 63.
Id.
Id.
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humans will be conducted after these
S•
•
72tests have been performed and the
chance of harm to humans minimized.
To date the NIH has approved five grants totaling $4.2 million dollars
to scientists focusing on existing human embryonic stern cell research, and
it has also issued thirty-two administrative supplements to already existing
awards. 3 These supplements will allow thirty researchers to incorporate
embryonic stem cell research into their current research.74 To help further
research in this area, the NIH has instituted a new stem cell task force, led
by the Director of the National Institute on Deafness and Other
Communication Disorders, Dr. James Battey.75 Its job will be to "provide
direction for the future in the form of recommendations for NIHsupported research initatves.

President'sCouncil on Bioethics Proposal
President Bush, in his speech to the nation on August 9, 2001,
instituted the President's Council on Bioethics to "monitor stem cell
research, to recommend appropriate guidelines and regulations, and to
consider all of the medical and ethical ramifications of biomedical
innovation., 77 The Council, chaired by Dr. Leon Kass (a leading
biomedical ethicist from the University of Chicago), among others, consists
of doctors, scientists, ethicists, lawyers, and theologians.78
Following the President's speech to the nation, the President's
Council met throughout a six-month period and on July 10, 2002 issued its
first report, entitled Human Cloning and Human Dignity. An Ethical
79.
Inquiry, in which the Council discusses both cloning to produce children
and cloning for biomedical research. 80 It unanimously recommends that
cloning to produce children should be banned. 81 However, on the topic of
cloning for biomedical research, the Council is split into a majority opinion
and a minority opinion.8 ' To reach their decision, the Council discussed
moral and public policy issues."' After significant discussion, the minority
B.

72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.

Id.
Id.
Id.
Zerhouni, supra note 63.
Id.
Bush, supra note 45.
Id.
See THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 1.
See id.
See id.
See id.
See id.
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opinion recommended that cloning for biomedical research be allowed
with regulationYg In contrast, the majority of the council recommended
that there be a "four-year moratorium on cloning-for-biomedicalresearch," with a "federal review of current and projected practices of
human embryo research, pre-implantation genetic diagnosis, genetic
modification of human embryos and gametes, and related matters, with a
view to recommending and shaping ethically sound policies for the entire
field."85
1. President's Council Minority Opinion
The Council members in favor of proceeding with cloning for
biomedical research stated that the moral case for proceeding with the
research involves an obligation to try to relieve human suffering and that
research on cloned human embryos is one more path to achieve this goal.86
These Council members note that four benefits of allowing cloning for
suffering include cloning to: improve
biomedical research to relieve human
S
87
the understanding of human disease; devise new treatments for human
disease; 88 produce immune-compatible tissues for transplantation;' 9 and
assist in gene therapy. 9°
Although these council members favor proceeding with cloning for
biomedical research, they have two different views of the moral issues.9'
One set of council members does not see any moral problems with such
research, as they do not attach a moral status to the early embryo; they
believe that an early human embryo should be treated just like any other
human cell. 9 Therefore, the main standards used in the research is that of
informed consent and scientific integrity. 93
The other set of council members favors cloning for biomedical
research, but has serious moral concerns, such as the status of a human
embryo, the creation of human embryos solely for use in research, the
development and use of cloned embryos past the first fourteen days, the
exploitation of women who choose to donate their eggs, and the

84. Id.
85. THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 1.

86. Id.
87.
88.
89.
90.
91.

Id.
Id.
Id.
Id.
See THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 1.

92. See id.
93. See id.
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implication that it might lead to cloning to produce children. 94 Despite
their concerns, they still favor the research on human embryos, but only up
to the first fourteen days of development and with appropriate rules and
regulations to guide such research. 9 They favor the research because they
believe that the early embryo should not be given the moral status of a
human person, rather, should be allowed an intermediate moral status.
Such embryos are not created for destruction, but to a service of life and
medicine.96
The Council members that support cloning for biomedical research
propose that regulation be carried out by a regulatory agency, which would
control both federally and privately funded research. 97 This agency's
purpose "would be to enforce certain general standards for the handling
and use of cloned human embryos, to ensure that they are not created for
frivolous purposes, used irresponsibly, or treated in ways that go beyond
what American society deems morally acceptable."9 8 The council members
believe the agency should also be authorized to establish some or all of the
following: what can and cannot be done with the human embryos once
they are created, licensing of research on cloned embryos, guidelines on
informed consent, registration and monitoring of each cloned embryo,
establishment and enforcement of time after which an embryo may not be
used in research, monitoring and regulation of financial transactions
relating to research, and enforcement of regulations. 9 The members state
that this regulatory system is needed not only "to regulate and limit the use
of cloned embryos," but also to set "clear rules and limits to prevent
abuses."' ° The council members believe the regulatory structure for the
United States could be developed by studying the models already in place
in other countries such 0as the United Kingdom's Human Fertilisation and
Embryology Authority.1 '
2. President's Council Majority Opinion
The Council members proposing a moratorium or temporary ban on
cloning for biomedical research noted that neither the researchers,
patients, nor moralists could know to a certainty that there will be medical

94.
95.
96.
97.
98.
99.
100.
101.

See id..
See id.
See id.
See THE PRESIDENT'S COUNCIL ON
Id.
Id.
Id.
Id.

BIOETHICS,

supra note 1.
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benefits to allowing cloning for biomedical research.
The council
members also stated they had concerns with the respect or moral standing
that the early human embryo deserved, since, if inserted into a woman, the
embryo could potentially develop into a child.' 3 They noted that human
identity exists in the human embryo from conception and should not be
taken advantage of by scientific endeavors.' 4 These council members are
concerned that allowing cloning for biomedical research, even with
regulation, will create a slippery slope where one day it will be acceptable
to clone a human baby.' 5 Finally, the council members against cloning for
biomedical research state that they are not "closing the door on medical
progress," but believe that other avenues should be pursued instead of
using cloned embryos, even if such avenues are slower. °6
The council members proposing the moratorium note that this option
would allow for an "enlarged debate on a question about which people
currently differ (cloning-for-biomedical-research)."' 0 7
The council
members see several benefits to a moratorium on cloning for biomedical
research. A moratorium would allow for the following: continued research
in related fields to clarify the potential benefits of cloning for biomedical
research, institution of a regulatory structure, and time for further debate
on moral issues so that the decision on whether to continue or end the
moratorium can be made carefully.' It would also allow policy makers to
look at cloning for biomedical research in the context of embryo-research
instead of under human cloning.'0 9
C. Federaland State Laws
Debate concerning cloning in the United States Senate is growing due
to claims by Clonaid" ° that the first cloned human baby was allegedly born

102. See id.
103. See THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 1.

104. See id.
105. See id.
106. Id.
107. Id.
108. Id.
109. THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 1.
110. See David Chazan, Who Are the Raelians?, BBC NEws, Dec. 28, 2002, availableat
http://news.bbc.co.uk/2/hi/health/2610795.stm. The Raelians are a religious sect. The
group's founder, Claude Vorihon (Rael as he now is called), claims that he was contacted
by aliens and was told humanity was created in a laboratory (i.e. cloned) by people of a
different planet. Id.
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on December 27, 20021.1 and due to President Bush's request that
Congress "pass a law against all human cloning ' 2 in his State of the Union
address on January 28, 2003.
Both the United States House of Representative and Senate have
taken up the issue of cloning.1 3 After holding four hearings on cloning, the
House of Representatives passed a strict ban on all human cloning in July
2001.14 On March 5, 2002, the United States Congress debated a bill
proposed by Senator Sam Brownback that would impose criminal
penalties on any "attempts at transferring a human somatic cell nucleus
into a human egg," whether for cloning to produce children or for cloningfor-biomedical purposes."' 5 However,
116 at the end of the Senate term the
proposed bill had not been voted on.
On February 5, 2003, two bills were introduced into the Senate. One
bill, introduced by California Senator Dianne Feinstein and Utah Senator
Orrin Hatch, would outlaw cloning to produce children while allowing
cloning for biomedical research pursuant to regulation,"' including a
prohibition of using fertilized eggs fourteen days past conception, fines or
imprisonment for cloning-to-produce children, the inability for donors to
receive payment for Stheir118egg donations, and a requirement of informed
consent from the donors. The second bill, introduced by Kansas Senator
Sam Brownback and Louisiana Senator Mary Landrieu, again proposed
outlawing "all use of cloning technology involving human embryos."" 9
Some states have decided to bypass the federal government and the
President in the controversy of cloning for biomedical research. 1 O

111. Cloned Baby Claim Met with Doubt, BBC NEWS, Dec. 27, 2002, available at
http:fhnews.bbc.co.uk/2hi/health2608655.stm.
112. President George W. Bush, State of the Union (Jan. 28, 2003), available at
hitp:/Iwww.whitehouse.gov/news/releases/2003/01/20030128-19.html

113. See
INSTITUTES

OFFICE OF LEGISLATIVE POLICY AND
OF

HEALTH

AND

CONGRESS,

ANALYSIS: LINKING THE NATIONAL

LEGISLATIVE

UPDATES,

available at

http://olpa.od.nih.gov/1egislation/lO7/session2/7cloning.asp (last visited Mar. 6, 2003).
114. Id.
115. Tabitha M. Powledge, US Cloning Debate Gathers Steam, THE SCIENTIST, Mar. 7,
2002, availableat http://www.biomedcentral.com/news/20020307/03.

116. See id.
117. Lisa Friedman, Cloning Spurs Senate Sparring. Stem Cell Research Also on Agenda
as Rival Bills, Celebrity Activists Bring New Twists to Controversial Debate, OAKLAND
TRIB., Feb. 6, 2003, available at 2003 WL 8912473.
11& Id.
119. id,
120. See Amanda Onion, Research Revolution? New California Stem-Cell Law Defines
Federal Policy, Other States May Follow, ABC NEWS, Oct. 8, 2002, available at
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California is the first state to directly challenge the President by passing a
state law that encourages embryonic stem cell research.12"' The bill states
various reasons why California will allow stem cell research. 2 Some of the
reasons noted are that there are millions of Americans suffering from
crippling and degenerative diseases and while the cost of treatment for
those diseases is high, there is hope that stem cell research may lead to
substantial treatments for them. Other justifications include the United
States and California being leaders in biomedicine and biotechnology.
California's biotechnology industry is critical to the state's economy, and
open and public research is 123essential to realizing the goal of finding new
treatments for such diseases.
The California bill permits "the derivation and use of human
embryonic stem cells, human embryonic germ cells, and human adult stem
cells from any source, including somatic cell nuclear transplantation" with
review by an approved institutional board. 114 The bill also states a medical
professional in charge of fertility treatments shall give his or her patients
appropriate information to make voluntary decisions as to what to do with
their surplus embryos, be it storing them, donating them to other couples,
125
discarding them, or donating them to research (via written consent).
Valuable consideration, not including "reasonable payment for the
removal, processing, disposal, preservation, quality control, storage,
16
transplantation, or implantation," is strictly prohibited under the bill. 1
Other states are following California's lead. Senators in the New
Jersey Legislature have introduced a bill similar to California's, but the bill
has yet to be ratified. 1 7 The New Jersey bill states similar reasons
T
28 as to
why embryonic stem cell research will be allowed in New Jersey.
The
bill, like California's, permits "the derivation and use of human embryonic
stem cells ...including somatic cell nuclear transplantation." 29 It states
that an institutional board will review each case to make sure that ethical

http://abcnews.go.com/sections/scitech/DailyNews/stemlaws02lOO8.html (last visited Mar. 6,
2003).
121. Scott Duke Harris, Fighting the Feds: Bush Gets a Taste of Big State's Contrarian
Ways, SAN JOSE MERCURY NEWS, Nov. 3, 2002, availableat 2002 WL 102438066.

122. See S.B. 253, 2001-2002 Reg. Sess. (Cal. 2001).
123. Id.
124. Id.

The board

would review and approve

considerations. See Onion, supra note 120.
125. S.B. 253, 2001-2002 Reg. Sess. (Cal. 2001).
126. Id.

127. See Onion, supra note 120.
128. See A.B. 2840, 210th Leg. (N.J. 2002).
129. Id.
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and medical implications are considered and provides for informed
consent for patients receiving fertility treatment and prohibits receipt of
valuable consideration for human embryos.130
The only difference
between the two states' laws is that New Jersey's bill includes a penalty of
$50,000 and/or imprisonment for people that violate the bill's provisions,
131
whereas California does not mandate such a penalty in its instituted bill.
Other states such as New Mexico and Oregon are currently considering
similar bills of their own."'
Maryland and Virginia are instead
"considering bills to create special panels dedicated to exploring the
potential of stem-cell research."'33 The biggest advantage of these laws is
that they would give researchers not only funding, but also a work
environment free from hostility.13

In December 2002, Stanford University announced its intention to
clone human embryos for stem cell research, taking advantage of
California's law allowing cloning for biomedical research and "becoming
the first U.S. university to publicly embrace the politically charged
procedure. 1 5 Stanford said the project will be funded with public and
private funds, and will be geared primarily to finding cures for cancer.136
However, Stanford has also stated that it plans to share stem cells with
outside researchers.' For now, the California bill and other states passing
such bills provide researchers and proponents of 38cloning for biomedical
research the "legal cover" to pursue their research.1

III. CLONING FOR BIOMEDICAL RESEARCH IN OTHER COUNTRIES
In contrast to the hesitation in the U.S., various other countries have
forged ahead in cloning for biomedical research.'39 This section of the

130. id.
131. Compare S.B. 253, 2001-2002 Reg. Sess. (Cal. 2001), with A.B. 2840, 210th Leg. (N.J.
2002).
132. See Onion, supra note 120.
133. Id.
134. See id.
135. University to Clone Embryos; Goal is to Produce Stem Cells, NEWSDAY, Dec. 11,
2002, at A18.
136. Id.
137. Id.
138. See Carl T. Hall, Stem Cell Storm's Eye Over UCSF,Stanford; State Law Called Key
in Fostering Research Opposed by Bush, SAN FRANCISCO CHRON., Dec. 21, 2002, at Al.
139. See Tim Friend, Saudis Take Lead on Stem-Cell Cloning, USA TODAY, July 8, 2002,
available at http://www.usatoday.com/news/healthscience/science/2002-07-09-arabstemcell.
htm.
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comment discusses in detail the stance on cloning for biomedical research
in three countries: the United Kingdom, Australia, and Singapore; and
provides an overview of the policies in Canada, Saudi Arabia, Germany,
Japan, and the United Nations.
A.

United Kingdom
The United Kingdom has been one of the leaders in human
fertilization and embryology since the 1990s."'0 In 1984, the Committee of
Inquiry into Human Fertilisation and Embryology, chaired by Baroness
Warnock, recommended the regulation of research on human embryos. 4 '
After extended discussions, the government of the United Kingdom
adopted the Committee's recommendations in the Human Fertilisation
and Embryology Act of 1990 (the Act). 42 The Act established the Human
Fertilisation and Embryology Authority (HFEA), which gives
the
13
discretionary right to issue licenses for research on human embryos.
The Act prohibits the research on embryos older than fourteen days
and may not be performed unless the HFEA issues a license.'" The
HFEA will only grant a license if they are satisfied that the use of embryos
is necessary for the purposes of research and only if the embryos are used
for the following purposes:
(a) promoting advances in the treatment of infertility, (b) increasing
knowledge about the causes of congenital disease, (c) increasing
knowledge about the causes of miscarriages, (d) developing more
effective techniques for contraception, (e) developing methods for
detecting the presence of gene or chromosome abnormalities in
embryos before implantation,
or for such other purposes as may be
14
1
specified in regulations.
In 1998, the HFEA and the Human Genetics Advisory Commission
(HGAC) jointly recommended that two more licensing purposes be added
to those mentioned above: "development of methods of therapy for
mitochondrial disease; and the development of therapeutic treatments for
diseased or damaged tissues or organs.' ' 146 In September of 1999, the
government of the United Kingdom assembled a group of experts to
analyze the feasibility of research on human embryos and in 2001, the

140.
141.
142.
143.

UK Committee, supra note 8, para. 1.1.
Id. para. 1.2.
See id.
Id.

144. Id. para. 1.3.
145. Id.
146. UK Committee, supra note 8, para. 1.7.
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House of Commons and then the House of Lords passed the Human
Fertilisation Embryological Regulations of 2001."' The Regulations added
three new purposes to the Act of 1990: "(a) increasing knowledge about
the development of embryos, (b) increasing knowledge about serious
in developing
disease, or (c) enabling any such
148 knowledge to be applied
treatments for serious disease.,
In December of 2001, the government of the United Kingdom
introduced and made law the Human Reproductive Cloning Bill, which
prohibited cloning to produce children.149 In March 2001, the House of
Lords appointed a committee "to consider and report on the issues
connected with human cloning and stem cell research arising from the
Purposes)
and
Embryology
(Research
Human
Fertilisation
Regulations."..
On February 13, 2002, this committee made recommendations on the
following topics: stem cell research, status of the early embryo, cell nuclear
With regard to
replacement and cloning, and legislation and regulation.'
advantages
of using
stem cell research, the council discussed the potential
152
embryonic versus adult stem cells for research.
The committee's report states that research on mice has shown it is
possible to isolate embryonic stem cells "from the blastocyst, culture and
multiply them in the laboratory, in principle indefinitely, and induce them
to differentiate into a wide range of different cell types."'' 3 Researchers
have also taken these same cells, inserted them into eggs, implanted them
into female mice and achieved normal offspring. 54 The committee sees
this as proof that embryonic stem cells "can be grown and manipulated
safely in culture" and that they will develop into all cell types of the
body. 55 Because of such research, the committee believes there is
significant potential to develop a wide range of therapies from human
embryonic stem cells.156

147.
148.
149.
150.
151.

Id. paras. 1.8-1.10.
Id. para. 1.10.
Id. para. 1.14.
Id. para. 1.15.
The United Kingdom Parliament, Stem Cell Research Committee, Summary of

Conclusions and Recommendations, Feb. 13, 2002, available at http://www.parliament.the-

stationery-office.co.uk/pa/ld/ldstem.htm.
152. See UK Committee, supra note 8, paras. 3.3-3.14.
153.
154.
155.
156.

Id. para. 3.3.
Id.
See id.
See id. para. 3.22.
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The committee also noted a potential for using adult stem cells for
research because there is already proof that haematopoietic stem cells
have helped to treat leukemia and other blood disorders."' One of the
greatest advantages to using the adult stem cells of an ailing individual to
treat their disease is that it avoids rejection by their immune system. The
committee also notes possible limitations to using adult stem cells, such as:
"isolation of neural cells from a patient's brain," 159 problems to date of
isolating and growing stem cells in culture, difficulty of differentiating the
adult stem cell into other cell types, and lack of sufficient research into this
subject."'O Therefore, the committee recommends that research on
embryonic and adult stem cells continue concurrently since neither
research "alone is likely to meet all therapeutic needs. 16' If research on
adult stem cells is successful in the future, research on embryonic stem
cells could become unnecessary.162
In their report, the committee discusses in detail the status of an early
embryo. 63 First, they noted the Human Fertilisation and Embryology Act
of 1990 awards the early embryo a "special status but not one that justifies
its being accorded absolute protection. "'64 Then the committee went on to
say that just because a human tissue or cell is alive is not enough to award
the embryo has a potential to become
it full right to life, 16' and just because
6
will. 1
it
mean
not
does
it
a person,
The committee also noted that currently there is legislation allowing
abortion (which destroys embryos), in vitro fertilization (which creates
surplus embryos, most of which are eventually destroyed), and research on
human embryos (the 1990 Act).- 67 Therefore, based on the current laws
and social attitudes, the committee concluded that research on human
embryos should not be prohibited6

The committee upheld the time allotted to doing research on human
embryos at fourteen days as established in the 1990 Act.169 This time frame
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.

See id. para. 3.8.
UK Committee, supra note 8, para. 3.9.
Id. para. 3.10
See id. paras. 3.11-3.14.
Id. para. 3.22.
Id.
See id. paras. 4.1-4.28.
UK Committee, supra note 8, para. 4.5.
Id. para. 4.14.
See id. para. 4.12.
Id. para. 4.20.
Id. para. 4.21.
Id. para. 4.22.
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has been widely accepted since in the first two weeks the nervous system in
an embryo has still not developed.7 0 Although the committee did not limit
research on human embryos, it did recommend embryos should not be
created just for research purposes unless "there is a demonstrable and
exceptional need which cannot be met by the use of surplus embryos.' 7'
The committee also recommended that cell nuclear replacement (CNR) be
permitted under strict regulation, 7 ' that the prohibition on reproductive
cloning in the Human Reproductive Cloning Act of 2001 be endorsed, 73
and that the HFEA should continue
to regulate research on human
17 4
embryos including the use of CNR.
According to the committee, the government should review the
scientific advances in adult stem research and therapies by the end of the
decade to see if "research on human embryos is still necessary."'1 75 Some of
the other recommendations with regard to legislation and regulation
proposed by the committee were: government review of funding of the
HFEA, 17 HFEA review of licensing,"' separation of clinical and research
roles for donation of eggs or embryos, developing a committee for
review of clinical studies involving stem cells, 179 developing a stem cell
bank responsible for keeping stem cell lines and monitoring their use,180
and making sure that informed consent from donors is obtained in regards
to embryonic stem cell lines for research. 8 '
Two days after the committee's report, the HFEA "approved
applications from two research groups to develop stem cell lines from
human embryos."'' 8 One of the groups was licensed to develop stem cell
lines to be used in developing therapies for Parkinson's disease. and the
other group "has been approved to use stem cells to investigate blastocyst
development and stem cell lines for diabetes and Parkinson's disease."'8 3

170. See UK Committee, supra note 8, para. 4.22.
171. Id. para. 4.28.
172. Id. para. 5.4.
173. Id. para. 5.21.
174. See id. para. 5.24.
175. Id. para. 8.4.
176. See UK Committee, supra note 8, para. 8.4.
177. See id. para. 8.6.
178. Id. para. 8.21.
179. See id. para. 8.23.
180. See id. para. 8.29.
181. See id. para. 8.33.
182. Susan Mayor, Human Stem Cell Research Gets Green Light, THE
2002, availableat http://www.biomedcentral.com/news/20020305/03.
183. Id.
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The licenses were granted for the harvesting of stem cell lines from "spare"
embryos created for in vitro fertilization, but only after receipt of informed
consent by the donors. '8
After the report by the committee, the Medical Research Council in
the United Kingdom set up a National Stem Cell Bank Advisory
Committee to develop "principals and practice in relation to the ethical,
legal and regulatory issues associated with stem cell research and
banking.' 18 5 This committee is also working to generate standard donor
information, consent forms, information for scientists concerning which
licenses and accreditations they will need to be able to use the bank and do
their research.18' The stem cell bank is likely to house both adult and
embryonic stem cell lines."" The stem cell bank will be monitored by a
Steering Committee which will put together a "code of practice for the
bank and for the use of stem cell lines, and will regulate the use of
embryonic stem cell lines. ' ' 8 A local management committee and a User
and Clinical Liaison Committee will also 1be
89 established for the bank,
which will report to the Steering Committee.
Ian Wilmut, the leader of the team that cloned "Dolly the sheep,"'9'
stated that he plans to pursue funding for cloning and performing research
on human embryos.' 9' His research proposal encompassed taking cells
from patients with genetic diseases and using such cells to develop new
medicine to treat the diseases.' 9 To date, the proposal has still not been

184. Id.
185. Medical Research Council, House of Lords Report on Stem Cell Research, at
http://www.mrc.ac.uk/b3/index/public-interest/public-topical-issues/publicstem
_cells/public-house of-lordsstemcell-report.htm (last visited Mar. 6, 2003).
186. Id.
187. Medical Research Council, supra note 3.
188. Id.
189. Id.
190. See Tim Beardsley, A Clone in Sheep's Clothing, SCIENTIFIC AMERICAN, Mar. 3,
1997, available at http://www.sciam.com/article.cfm?articlelD=0009B07D-BD4-1C59B882809EC588ED9F. "Dolly the sheep" was created by a team of scientists at the Roslin
Institute in the UK (funded by PPL Therapeutics in Edinburgh, a biotechnology company).
The researchers extracted DNA from adult cells (in Dolly's case the udder of an ewe) and
inserted them into eggs of sheep that had their natural nucleus removed. The eggs were
then cultured for a time and implanted into sheep that carried them to term. The cloned
sheep, "Dolly the sheep," is an exact replica of the sheep that provided the adult cell. Id.
191. James Meek, Cloning Team Looks to Human Embryos, GUARDIAN UNLIMITED,
Oct. 14, 2002, availableat http://www.guardian.co.uk/uk-news/story/0,3604,811258,00.html.
192. Id.
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approved by the Roslin Institute where Professor Wilmut conducts his
research 9
B. Australia
Australia has a long history of considering human embryonic
research.1 94 In 1982, the National Health and Medical Research Council
(NHMRC) "issued guidelines on the ethical aspects of research related to
the use of assisted reproductive technology (ART) [or in vitro
fertilization].' 95 In 1985, the Senate established a committee to look into
the Human and Embryo Experimentation Bill of 1985 and to see if the
research and manipulation of human embryos should be allowed.1 96 The
committee concluded that the embryos deserved respect and required
protection from destruction.
In 1993, the Australian Health Ethics Committee (AHEC) started to
review the NHMRC guidelines and in June of 1996, it released the Ethical
Guidelines on Assisted Reproductive Technology.19 This guideline noted
a variety of prohibited or unacceptable practices for embryos, but
proposed allowing the use of excess embryos from in vitro fertilization "for
research that may damage or destroy the embryo, under exceptional
circumstances."' 99 The AHEC, after releasing these guidelines, stated that
all states should introduce comprehensive assisted reproductive technology
legislation and recommended that the Commonwealth Minister for Health
enact legislation in states that refused9
In 1998, the Minister for Health and Aged Care asked the AHEC to
provide him with a report on the "scientific, ethical and regulatory

193. Id.
194. See generally SENATE
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2002
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OF THE RESEARCH INVOLVING EMBRYOS AND PROHIBITION OF HUMAN CLONING BILL

(October

2002).

available

at

emb cloning/report/contents.htm (reviews the history of the debate regarding cloning in
Australia, including cloning for biomedical research and cloning to produce children)
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195. Id. at 3. The NHMRC is the peak body of funding health and medical research in
Australia. They only fund proposals for research that have been approved by the ethics
and biosafety committees and that meet all the Commonwealth. State, and Territory laws.
NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL, STEM CELLS DERIVED FROM
EMBRYOS, Aug. 29, 2002, available at http://www.nhmrc.gov.au/issues/
HUMAN

stem cell.htm (last visited Mar. 6,2003).
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199. Id. at 4.
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considerations relevant to cloning of human beings. 2. 1 In this report, the
AHEC recommended the Government of Australia prohibit cloning to
produce children, that all states limit their research on human embryos to
the principles set out by the NHMRC, that statutory authorities be
instituted to regulate such research, and that the Minister should
encourage discussions on the potential benefits and detriments of the
development of cloning techniques.2 2
In August 1999, the Minister for Health and Aged Care requested
that "the House of Representatives Standing Committee on Legal and
Constitutional Affairs" review the 1998 AHEC report.2- 3 In their report,
released in August 2001, the majority of the Committee recommended:
"the enactment of legislation to regulate human cloning and stem cell
research;, 20 4 that this legislation include a ban on cloning to produce
children with criminal penalties if the ban is not followed; and that a
national licensing body be established to issue licenses for research, and
The Committee
for the creation and use of embryonic stem cells. 2
minority stated that they were opposed to this research as it included the
206
destruction of human embryos.
In December 2000, the government of Australia passed the Gene
This bill banned "human cloning, certain
Technology Bill 2000.2 "
experiments involving animal eggs and certain experiments involving
putting human and animal cells into a human uterus."' '
On April 5, 2002, the Council of Australian Governments (COAG)
decided that "the Commonwealth, States and Territories would introduce
legislation banning human cloning and other unacceptable practices and
establishing a national regulatory framework for the use of excess assisted
reproductive technology (ART) embryos."'2 9 The COAG also agreed that
210
the NHMRC would administer the instituted regulatory system.
Consistent with this agreement, the Commonwealth, on June 27, 2002,

201. Id.
AFFAIRS COMMITTEE,

supra note 194, at 4.

COMMUNITY AFFAIRS COMMITTEE,

supranote 194, at 5.
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203. Id. at 4.
204. id. at 5.
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introduced the Research Involving Embryos and Prohibition of Human
Cloning Bill 2000 into Parliament for approval2.
The main objective of this act is to concentrate on the ethical concerns
surrounding cloning. 12 Therefore, the act prohibits certain practices and
regulates the use of certain embryos created via in vitro fertilization. 3
This bill specifically prohibits and makes it an offense to create cloned
human embryos, to place a cloned human embryo in a human or animal,
and to import a cloned human embryo into or out of Australia.2 4 The bill
defines a cloned human embryo as one "that is a genetic copy of another
living or dead human, but does not include a human embryo.""' 5 This act
would prohibit the creation of human embryos by in vitro fertilization or
cloning techniques such as SCNT or other methods, for specific use in
research either to derive embryonic stem cells or for any other reason not
216
The act also prohibits the
intended to achieve pregnancy in a woman.
development of human embryos outside the body of a woman after
fourteen days."'
The act does allow the use of a human embryo in research if it is in the
course of fertility treatment, in excess after a couple's fertility treatments
(only with the couple's authorization), and only if the use has been
218
The only uses of excess human
approved in accordance with a license.
are
allowed
under
this
bill
are
either "an exempt use under
embryos that
2 9
the legislation; or licensed by the NHMRC Licensing Committee.""
Exempt uses include storage of the embryos, removal from storage,
transportation of embryos, observation, allowing them to die, diagnostic
tests to see if they are suitable for implantation, donating them to another
woman for the purpose of pregnancy, and any other use prescribed by
regulation. 220 Licensing will be required for research into the effectiveness
of new culture medium used for in vitro fertilization practice, further
understanding the development and fertilization of embryos, training of
personnel that will be conducting in vitro procedures, improvement of the
current in vitro procedures and derivation of stem cells.2 1
211.
212.
213.
214.
215.
216.
217.
218.
219.
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221.
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The NHMRC will ensure that after a license is issued, the researchers
have obtained consent from the donors of the embryos, that the use of the
embryos is in accordance with the restrictions instituted by the donors, and
that if the uses of the embryos will destroy or damage the embryos, only
embryos created before April 5, 2002 are used. 2 ' The bill also states how
the NHMRC Licensing Committee will be instituted, how it will operate,
223
and its reporting requirements
It also includes information on how
confidentiality will be kept, how licenses will be reviewed,"' how the
legislation will be monitored and enforced,22 and how "all States and
Territories will [have to] introduce . . .a comprehensive and effective
national scheme banning
certain practices and regulating certain uses of
''2 7
excess... embryos. 2
The bill, in accordance with COAG's views, lifts the prohibition on
April 5, 2005 of using excess embryos created before April 5, 2002. It also
provides for an independent review by the NHMRC of this bill two years
228
after it receives Royal assent.
The House of Representatives split the Research Involving Embryos
and the Prohibition of Human Cloning Bill 2002, referenced above, into
two bills: the Prohibition of Human Cloning 2002 and the Research
Involving Embryos Bill 2002.229 The House of Representatives passed the
Research Involving Embryos Bill 2002 on September 25, 2002. 2' 0 The only
difference between this bill and the Research Involving Embryos and
Prohibition of Human Cloning Bill 2002 is that it only deals with
regulation of activities that involve using human embryos; it does not
include the prohibition of cloning to produce children.231
On August 21, 2002, the Senate appointed the Community Affairs
Legislation Committee to review the combined bill (the Bill) and gather
information from the community on the issue of research involving

222. Id. at 18.

223. See id. at 19-21.
224. See id. at 22-23.
225. See id. at 24.
226. See id. at 25-26.
227. NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL, supra note 209, at 27.
228. Id. at 28.
229. COMMUNITY AFFAIRS COMMITTEE, supra note 194, at 116.
230. See Parliament of the Commonwealth of Australia, House of Representatives,
Research Involving Embryos Bill 2002, H.R. REP. No. 02183, available at
http://search.aph.gov.au/search/Parllnfo.ASP?action=view&item=0&resultslD=lDI8Os
(Oct. 13, 2002).
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embryos. On October 23, 2002, the committee submitted its findings in a
split decision. 33 The majority of the committee concluded that surplus
human embryos should not be used for destructive research (i.e., research
that purposely destroys the embryo), that research on pre-existing human
embryonic stem cells can continue as it is not dependent on the passage of
this bill, that other research alternatives should be sought that do not
include the destruction of embryos, and that amendments to this bill
should be considered to account for the inadequacies of the current bill.14
The minority believes that the Bill should be passed, because if it is
not, the country will have inconsistent regulation throughout its States and
Territories, and no regulatory agency would be instituted to oversee this
type of research. The minority also believes that by not passing this Bill,
researchers will be hampered as they will only have access to the existing
stem cell lines, which will not be acceptable for future clinical research,
and the country might be hurt as scientists and companies might leave to
find liberal regulations in other countries.236
With regard to stem cell research, the minority stated that embryonic
stem cell research should not be constrained or prohibited, as there is
strong possibility that therapies may be developed from such research. 231
They also noted that just because adult stem cell research might lead to
cures or treatments of diseases, that both embryonic and adult stem cell
research should be continued, "with a view to understanding their relative
merits and disadvantages." 23
The minority also cites various reasons for the eventual need of
embryonic stem cell lines, one being the FDA's prohibition of clinical trials
with the current embryonic stem cell lines as they were created using
mouse feeder cells, which could potentially transmit diseases to humans. 239
Another reason cited in favor of the creation of additional embryonic stem
cell lines is that a larger panel of stem cell lines might be necessary to
address immunological rejection. 240
On November 28, 2002, the Parliament's Upper House voted to
permit 70,000 frozen embryos that had been created for in vitro
232. COMMUNITY AFFAIRS COMMITTEE, supra note 194, at 1.
233. See id. at vii.
234. Id. at 140.
235. Id. at 145-46.
236. Id. at 146. The "[e]xisting stem cell lines have been created with mouse feeder cells;"
therefore, research with human cells will eventually be needed. id. at 157.
237. COMMUNITY AFFAIRS COMMITTEE, supra note 194, at 152.
238. Id. at 154-55.
239. See id. at 157.
240. See id. at 158.
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fertilization be used for stem cell research. 24' However, researchers in
Australia will not be allowed to create new embryos for research purposes,
as the Prohibition of Human Cloning Bill 2002 makes it an offense to
"create an embryo for research; engage in trade of human eggs, sperm or
embryos, including giving (and accepting) financial inducements, including
[and] create embryonic stem cell lines from somatic cell
handling 24fees;
2
,

donors.

The city of Melbourne welcomes the news by the parliament, since it
will be the home for the Center for Stem Cells and Tissue Repair set to
open this year.24' Scientists that will be a part of the Center believe that
the Center backed by the now-ratified law will help to make Australia one
244
of the leaders in stem cell research.
C. Singapore
In a desire to benefit from the scientific advances both socially and
economically, the Government of Singapore has decided to continue
24
1
research on embryonic stem cells, but within a "regulatory framework.",
The government based its decision on the Bioethics Advisory Committee's
(BAC) report of June 2002, entitled Ethical, Legal and Social Issues in
246
Human Stem Cell, Research, Reproductive and Therapeutic Cloning.
The BAC was established in December 2000 by Singapore's Cabinet
"to examine the ethical, legal and social issues arising from biomedical
research and development in Singapore, and to recommend policies to the
Ministerial Committee for Life Sciences on those issues., 247 The
committee requested input from scientists, sociologists, theologians,
professional organizations, and the public in general to understand the
concerns and sentiments of these groups regarding embryonic stem cell
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at http://www.cnn.com/2002/WORLD/asiapcflauspac/12104/australia.stemcells.
242. COMMUNITY AFFAIRS COMMITrEE, supra note 194, at 176.

243. Holloway, supra note 241.
244. See id.
245. Tony Tan Keng Yam, Determinism and Reductionism: Genetic Science and the
Person

(July

19,

2002),

available

at

http://www.bioethics-singapore.orgfbac/

detailed.jsp?artid=38&typeid=4&cid=6&bSubmitBy=false.
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research. It also took into consideration what policies and regulations
other countries have instituted.2 49
The committee discusses the ethical concerns of allowing stem cell
research at great length,2 ° stating that these issues need to be addressed so
"science and the new medical treatments arising from it" can proceed. 251 It
also uses two principles to guide their recommendations that the results of
252
research be both just and sustainable. 2 The BAC defines just as an
"obligation to respect the common good, that there must be fair sharing of
the costs and benefits, 25 3 and sustainable as "an obligation to respect the
needs of generations yet unborn., 214 Finally, it also notes that their
of the spectrum of views held by
recommendation is based on "balancing
25
various sectors" of their society.
In its report, the BAC discusses embryonic stem cells, embryonic

germ cells, and adult stem cells,2" but notes that embryonic stem cells seem

to have the highest potential for researchers, as they are pluripotent (i.e.,
could develop into any cell of the body).2 7
The BAC recommends that the derivation and use of adult stem cells
'58
It states that since
be allowed with the informed consent of the donor.
other types of tissues, such as biopsy specimens or tissues removed during
surgery, have been used in research to develop increased knowledge and
is no reason why adult stem cells should not
treatments for diseases, there
259
well.
as
research
for
be used
The committee also recommends that the derivation and use of germ
cells be allowed with the informed consent of the donor, but the consent
has to be independent of the decision to abort a fetus. 26° Embryonic germ
cells are cells that "originate from the primordial reproductive cells of the
developing [fetuses] and may be sourced from cadaveric [fetuses].,,2"' The
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249.
250.
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255.
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See id. at 10-13.
See id. at 14-20.
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BAC notes that abortions are currently legal in Singapore, and like
12
donating tissue, donating aborted fetal tissue should be allowed .
The BAC notes that one of the problems with allowing the derivation
263
and use of embryonic stem cells is the status of the embryo. It adopts an
intermediate position where the embryo would be given a "special status
as a potential human being, but is not of the same status as a living child or
adult. 268 It also states that this respect would be weighed against the
benefits of the proposed research; it would not be absolute.26 Therefore,
the BAC concludes that it supports embryonic stem cell research, but only
when medical benefit would come from such research. 66
Noting that embryonic stem cells can be derived from various sources,
the BAC recommends that when embryonic stem cells are "required for
research, they should, wherever possible, be drawn first from the existing
ES [embryonic stem] cell lines, 26 7 then from surplus embryos no longer
needed for fertility treatments (donated and with informed consent),"' and
lastly, if necessary, by the creation of human embryos through SCNT or
other cloning technology (i.e., cloning for biomedical research). 6 9
The BAC acknowledges that there are potential advantages in cloning
for biomedical research such as the "opportunity to derive stem cells which
are genetically compatible with the person being treated," avoiding
rejection problems if used in treatment, and enabling "scientists to learn
about the mechanisms of reprogramming adult cells to behave like
embryonic stem cells," possibly making it unnecessary to harvest
embryonic stem cells."" Therefore, the BAC adopts the position that
cloning for biomedical research should be permitted, but only "after the
satisfaction of stringent conditions and guidelines as evaluated by a
statutory body to be set up to license, audit and control human stem cell
research."27 '
The BAC also acknowledges that there might be a possibility that
cloning for biomedical research might lead to cloning to produce children,
but that this possibility would be eliminated by strict prohibition of

262. Id. at 23.
263. Id. at 24.
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implantation of a cloned embryo into a womb.1 The council recommends
a complete ban on "the implantation of a human embryo created by the
application of cloning technology into a womb, or any treatment of a
intended to result in its development into a viable
human 27embryo
, 3
infant.
The committee also recommends that only embryos that are less than
fourteen days old be used to derive human embryonic stem cells, as this is
before the development of the nervous system. 274 Finally, the BAC
emphasizes that informed consent must275also be required "from the donors
of surplus embryos, gametes and cells.,
With regard to legislation, the BAC recommends the creation of "a
statutory body to license, control and monitor all human stem cell research
conducted in Singapore, together with a comprehensive legislative
framework and guidelines., 276 The committee notes that the United
Kingdom's Human Fertilisation and Embryology Authority could be used
as a model in the development of Singapore's oversight authority.27' The
BAC states that the statutory body would also be able to audit any
research involving human stem cells, instate and enforce penalties for
deviation of the licenses, and draft provisions278 regarding "informed
consent, commerce and sale of research materials.,
With regard to informed consent, the BAC recommends that donors
of surplus embryos, cadaveric fetal tissue, eggs, and/or cells, be able to
make informed voluntary decisions as to whether and how they choose to
donate.2 79 The donation should not be for financial or any other type of
benefit to the donor, but it should not preclude the donor from receiving
treatments from any medical treatment later developed. °
Finally, the BAC states that it believes the recommendations in its
report "would lead to 'just' and 'sustainable' results. The results would be
'just', in that research with tremendous potential therapeutic benefits to
mankind will proceed. The results would be 'sustainable' as such research
future generations, especially with
has little biological or genetic impact 2on
81
the ban on the reproductive cloning.,
272.
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Richard Sykes, the chairman of Singapore's biomedical sciences
International Advisory Council (IAC),stated that now that Singapore has
set guidelines for stem cell research, they have to attract scientists and
researchers in that area. 282 He stated that having clear guidelines and
government funding will not only help calm the fear of the public, but will
also make sure that the research is not driven underground."'
Following the backing of the government, companies in Singapore,
such as ES Cell International, are planning their advances into the world of
stem cell research.' 84 ES Cell International would like to be one of the first
companies
in the world to market cloned embryonic stem cells for clinical
t 285
trials.
The company has stated it wants to create ten colonies of
unprogrammed cells nourished from human cells (as opposed to animal
cells) in an effort to make the cells safe for treating patients.9 It is feared
that if the existing stem cell lines were used for treatment of patients, there
would be risks of transmitting animal diseases to the patients. U 7 Therefore,
the company hopes that its plan will not only give scientists new cell lines
to use in developing treatments in the world but will also
86 foster an
increased pace of research in cloning for biomedical research.
D. Other Countriesand the United Nations
1.Canada
In Canada, the Canadian Royal Commission on New Reproductive
Technologies issued a report in 1993 including the recommendation that
certain research practices be prohibited and that a national regulatory
agency be instituted to govern permissible assisted human reproductive
activities. 89 Following this recommendation, the Canadian Government
and Health Canada consulted with the public and other interested parties
and in July 1995, the Canadian Government issued a "voluntary
moratorium on nine applications of human reproductive and genetic
technologies as the first phase in the development of an overall framework

282. Audrey Tan, S'pore Now Needs to Attract Experts for Stem Cell Research:Legislative
Framework and Necessary FundingAlready in Place, THE Bus. TIMES SINGAPORE, Oct. 30,
2002, availableat LEXIS, News & Business, Major World Publications.
283. Id.
284. See Firm Here to Grow Top-Grade Stem Cells, STRAITS TIMES, Oct. 31, 2002,
available at 2002 WL 100444386.
285. Id.
286. Id.
287. Id.
28& Id.
289. COMMUNITY AFFAIRS COMMITTEE, supra note 194, at 108.
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to regulate these technologies. The applications included human embryo
cloning, sex selection, and the buying and selling of eggs, sperm and
embryos."': The Government also instituted an advisory committee to
291
monitor researchers' compliance.
In 1996, the Human Reproductive and Genetic Technologies Bill, Bill
291
C-47, was introduced. 2 It prohibited the selected items that previously
have been given a voluntary moratorium by the Canadian Government.9
This "Bill did not complete the legislative process before the calling of the
1997 federal election., 29 4 In May 2002, Bill C-56, An Act Respecting
Assisted Human Reproduction, was introduced.9 This bill would ban a
variety of activities, such as: "creating a human clone for any purpose
([i.e.,] reproductive or therapeutic purposes); creating an in vitro embryo
for any purpose other than creating a human being or improving assisted
reproduction procedures; maintaining an embryo outside the body of a
woman past the 14th day of development.., selling or buying human
embryos, or providing goods or services in exchange." 2' 9 The bill also
develops regulation for the use of human embryos including research
allowed and what to do with embryos that are no longer needed after
fertilization treatments: 9' It also includes that the Assisted Human
Reproduction Agency of Canada would be required to issue licenses to
ensure that guidelines are followed, as well as to ensure compliance by
inspection of facilities and maintenance of a donor/offspring registry. 98 To
date, the Canadian Parliament is still considering the Bill. 99
2. Saudi Arabia
Saudi Arabia has a wealth of financial resources and an increasing
biotechnology industry, and is planning to start a stem cell research
program including cloning for biomedical research.: °° At this time, details
on the Saudi Arabian research center have not been disclosed, but it has
301
been said that the center should be operational within a year.
290. id.
291. Id.
292. Id.
293. Id.
294. Id. at 109.
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296. Id.
297. Id. at 110.
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299. Id.
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One of the biggest differences between the United States' hesitancy
versus Saudi Arabia's eagerness to pursue embryonic stem cell research is
the difference in religious beliefs. 30 2 Under Islamic law, life begins at 120
days after conception, which eliminates the moral dilemmas faced by
Christian scientists in the United States concerning the status of early
embryos.3"3

3. Germany
Although Germany is not allowing the creation of embryos for the
purpose of harvesting their stem cells, in late March 2002, the
parliamentarians voted to "allow the import of embryonic stem cells for
scientific research, but only under close government control." 3°4 In July,
2002, Germany's Federal Cabinet issued regulations for the new
embryonic stem cell research law, which allows researchers to use
imported embryonic stem cells (created before January 1, 2002), but only if
no other alternatives to these cells can be found.3 ' The law also institutes
penalties of up to three years' imprisonment or up to 50,000 euros for
violations of this law.3°6

Germany has debated the allowance of embryonic stem cell cloning
and research extensively, "in part because of the Nazis' grisly legacy of
experimentation in eugenics."30 7 In November of 2001, the National Ethics
Council recommended that limited importation of stem cells be allowed
for research.30 8

Although some believe that the parliamentary decision is an advance
for embryonic stem cell research in Germany, it is actually not. °9 This is
because before this decision, there were no laws against the importation of
embryonic stem cell lines."' Now there will be restrictive laws regulating
how stem cell lines are imported.3 1
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4. Japan
In 2000, the Japanese National Government issued "legislation
governing human cloning and related techniques. 3 12 On June 6, 2001, the
Japanese government instituted a law banning cloning to produce
children.313 However, in October 2001, the government in Japan approved
guidelines for cloning for biomedical research, embryonic, and stem cell
research. 4 The guidelines included obtaining consent from donors before
using stem cells for research.315
5. United Nations
The United Nations has also taken up the discussion of embryonic
stem cell research. The United Nations International Bioethics Committee
(IBC) issued its report on April 2001. 316 After discussing the ethical,
religious and scientific views on embryonic stem cell research, the IBC
concluded that each nation should debate and decide whether to allow
embryonic stem cell research; that if such research is allowed, a regulatory
system should be set up to provide standards and guidelines; informed
consent should be observed in regard to using surplus embryos from in
vitro fertilization; alternative ways to harvest human stem cell lines should
be pursued (i.e. adult stem cell lines); and respect for human dignity and
the principles instated by the Universal Declaration of Human Rights of
1948 and the Universal Declaration on the Human Genome and Human
Rights of 1997 should be observed.317
In November 2001, the United Nations General Assembly adopted a
resolution establishing a committee to draft an international treaty on
human cloning. 18 However, after a year of deliberation, the committee is
still deadlocked because of conflicting views. 19 The United States'
312. CTV News Staff, What are Stem Cells?, CTV.ca 2002, available at http://www.
ctv.calservlet/ArticleNews/story/CTVNews/20020828/stemcel-bgd020828/Health/story (last
visited Mar. 6, 2003).
313. BIOETHICS ADVISORY COMMITrEE, supra note 247, at 17-18.
314. Id. at 17.
315. Id.
316. See
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available at http://www.unesco.org/ibc/en/reports/embryonic-ibc-report.pdf [hereinafter
IBC].
317. Id. at 13-14.
318. Cloning: U.S. and Vatican Oppose France and Germany over Proposed New Treaty,
STEM CELL WEEK, Nov. 4, 2002, available at 2002 WL 25857966 [hereinafter Cloning
Treaty].
319. Id.
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THE ETHICAL ASPECTS OF HUMAN EMBRYONIC STEM CELL RESEARCH

TULSA J. COMP. & INT'L L.

[Vol. 10.2

proposed draft of the treaty includes a moratorium on all human cloning
pending the institution of an international convention."' France and
Germany disagreed with the United States and proposed that the treaty
include a ban on cloning to produce children, leaving cloning for
biomedical research for future consideration."' Diplomats say that the
United States' proposal is endorsed by the Vatican, Philippines, Spain,
Italy, Argentina and Costa Rica.3 22 France states that the all-or-nothing
approach by the United States could delay the adoption of the treaty
banning cloning to produce children, which most countries agree is
323
urgent .
One of the problems of passing treaties through the United Nations is
the delay in ratification.324 For example, in this case, this treaty would have
to be approved by the General Assembly, and then it would have to be
signed and ratified by each individual country. 3 5 This process could take
326
at least two years.
IV. CONCLUSION

Although most nations agree and have passed laws banning cloning to
produce children, a worldwide consensus on the topic of cloning for
biomedical research seems virtually impossible. As noted by the United
Nations, cloning for biomedical research should be debated in each nation
individually before a world treaty can be passed, as there are great
differences between nations on their specific moral, religious and societal
beliefs.327
After reviewing the policies proposed or adopted by the countries
included in this comment, the United States should allow cloning for
biomedical research so that as a nation it can continue to be a leader in
biotechnology. As noted by the NIH's director Elias Zerhouni, scientists
involved in embryonic stem cell research are encountering problems with
the availability of the stem cells,328 as only the existing approved stem cell
lines can be used in research. This could not only lead to a lack of
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scientists interested in doing this type of research, but also to scientists
leaving the United States to perform their research in other countries.
The purpose of embryonic stem cell research is to develop cures or
help treat diseases that are currently killing or ailing millions of people in
the United States. The United States currently has laws that allow the
disposal of surplus embryos from fertility treatments and laws that allow
abortions, both of which terminate the life of embryos. Most of those
embryos, if allowed to come to term, would most likely constitute viable
human beings. The United States also allows research on tissues removed
from a patient's body, such as in the case of biopsies. Allowing research
on embryos that would be eventually disposed of, with informed consent
of the donor, would only be a progression of the currently allowed
practices. The ethical issues surrounding cloning for biomedical research
should not be ignored, but precedent should be followed in this regard.
Similarly, cloning embryos specifically to harvest their stem cells
should also be allowed. Creating cloned embryos should not be banned
because there might not be enough surplus embryos to use in research. As
the United Kingdom has proposed and implemented, an oversight and
regulatory committee (i.e., the HFEA)319 can prevent abuses, including
cloning to produce children by scientists, but still allow the research and
development of therapies for the ailing and dying by using embryonic stem
cells for research.
Since the United States has started the process of oversight with the
NIH in regard to research involving the existing human embryonic stem
cell lines 30 it should expand that process by allowing cloning for
biomedical research not only for the good of thft ailing, but also to keep its
scientists and remain a leader in biotechnology.

329. UK Committee, supra note 8, para. 1.2.
330. Press Release, supra note 47.
The author wishes to note to readers and reseachers that the information provided in
this comment changes rapidly and is current only as of Feb. 8, 2003.

